rawfin.tv
Argus Research Raises Novartis Price Target to $170
MarketsstocksAI Generated

Argus Research Raises Novartis Price Target to $170

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Argus Research has increased its target price for pharmaceutical giant Novartis AG (NVS) to $170. This adjustment reflects a positive outlook on the company's future performance.

pharmaceutical stocksanalyst ratingprice targetstock upgradeinvestment research

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks